
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2021-09-30 | 2022-09-30 | |
Income Statement | ||||||
Revenue | $6.4M | $9.9M | $21.7M | $3.6M | $4.9M | |
Gross Profit | $6.8M | $8.9M | $18.7M | $3.3M | $4.2M | |
Operating Income | -$9.8M | -$12.5M | -$29.5M | -$5.4M | -$9.1M | |
EBITDA | -$7.4M | -$7.6M | -$15.8M | -$2.5M | -$5.3M | |
Diluted EPS | -$0.65 | -$0.63 | -$1.33 | -$0.27 | -$0.40 |
Period Ending | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $15M | $22.1M | $10.9M | $43.7M | $16.2M | |
Total Assets | $23.9M | $32.9M | $25.3M | $132.7M | $161.2M | |
Current Liabilities | $2.6M | $3.3M | $3.3M | $8.3M | $14M | |
Total Liabilities | $3.1M | $3.6M | $3.5M | $15.5M | $28.3M | |
Total Equity | $20.8M | $29.4M | $21.8M | $117.3M | $132.9M | |
Total Debt | $694K | $965.7K | $241.7K | $11.2M | $7.9M |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2021-09-30 | 2022-09-30 | |
Cash Flow Statement | ||||||
Cash Flow Operations | -$8.4M | -$10.5M | -$14.8M | -$6.1M | -$4.7M | |
Cash From Investing | -$5.1M | -$10.5M | -$33.9M | -$1.7M | -$2M | |
Cash From Financing | $455.6K | $50.3M | $24.5M | -$37.1K | $24.6K | |
Free Cash Flow | -$13.5M | -$15.9M | -$23.7M | -$7.9M | -$6.6M |
Smart Eye AB is engaged in developing and marketing eye-tracking technology that can measure, calculate, and predict where a person is looking. The company’s eye-tracking technology and iMotions biosensor software platform are also used in behavioral research to enable research in academic and commercial sectors.
In the current month, SMTEF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SMTEF average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Smart Eye AB share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Smart Eye AB share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Smart Eye AB is a Sell and believe this share price will rise from its current level to --.
The price target for Smart Eye AB over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Smart Eye AB is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Smart Eye AB via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Smart Eye AB shares.
Smart Eye AB was last trading at $6.38 per share. This represents the most recent stock quote for Smart Eye AB. Yesterday, Smart Eye AB closed at $6.38 per share.
In order to purchase Smart Eye AB stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.